Siamenoside I
(Synonyms: 赛门苷 I;翅子罗汉果 I) 目录号 : GN10252A cucurbitane glycoside
Cas No.:126105-12-2
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Animal experiment: | The animal experiment lasts six days. The whole urine and feces of days 1-2 are collected as blank urine and feces samples, respectively. On days 3-5, the rats of test group are orally administrated with siamenoside I [50 mg/kg body weight, in normal saline (NS) solution] at 9:00, and all 72-h urine and feces are collected as drug-containing urine and feces samples, respectively. The rats of blank group are orally administrated with the same volume of NS. On day 6 at 9:00, the test and the blank group are treated with siamenoside I and NS again, respectively. After 1 h, blood sample is collected into a vacuum tube with sodium citrate as anticoagulant from rat heart under anesthesia. Then, the organs (heart, liver, spleen, lung, kidneys, stomach, small intestine, brain) and skeletal muscles of rats are collected and washed with NS, separately. All samples are kept at −80°C before further pretreatment. |
References: [1]. Yang XR, et al. Metabolites of Siamenoside I and Their Distributions in Rats. Molecules. 2016 Jan 30;21(2):176. |
Siamenoside I is one of the mogrosides that has several kinds of bioactivities.
In rat, the metabolic reactions of siamenoside I include deglycosylation, hydroxylation, dehydrogenation, deoxygenation, isomerization, and glycosylation. Siamenoside I and its metabolites are mainly distributed to the intestines, stomach, kidneys, and brain[1].
References:
[1]. Yang XR, et al. Metabolites of Siamenoside I and Their Distributions in Rats. Molecules. 2016 Jan 30;21(2):176.
Cas No. | 126105-12-2 | SDF | |
别名 | 赛门苷 I;翅子罗汉果 I | ||
化学名 | Siamenoside I | ||
Canonical SMILES | CC(CCC(C(C)(C)O)OC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)OC3C(C(C(C(O3)CO)O)O)O)C4CCC5(C4(CC(C6(C5CC=C7C6CCC(C7(C)C)OC8C(C(C(C(O8)CO)O)O)O)C)O)C)C | ||
分子式 | C54H92O24 | 分子量 | 1125.29 |
溶解度 | DMSO : 100 mg/mL (88.87 mM; Need ultrasonic); H2O : 50 mg/mL (44.43 mM; Need ultrasonic) | 储存条件 | |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.8887 mL | 4.4433 mL | 8.8866 mL |
5 mM | 0.1777 mL | 0.8887 mL | 1.7773 mL |
10 mM | 0.0889 mL | 0.4443 mL | 0.8887 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。